FIELD: medicine, oncoendocrinology, oncogynecology.
SUBSTANCE: in tumor tissue one should detect peroxidase activity, both before and after incubation with estradiol at concentration being 10-7 and 10-6 M, and peroxidase activity increase one should detect latent tumor estrogenosensitivity. The innovation enables to evaluate potential positive reaction to hormone therapy.
EFFECT: higher efficiency of detection.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING TUMOR HORMONE DEPENDENCE OF LOW-DIFFERENTIATED ENDOMETRIUM CARCINOMA AND ITS SENSITIVITY TO AROMATASE INHIBITORS | 2006 |
|
RU2317555C2 |
| METHOD OF ESTIMATING SENSITIVITY OF ENDOMETRIAL CANCER TO NEOADJUVANT APPLICATION OF AROMATASE INHIBITORS | 2008 |
|
RU2373857C1 |
| METHOD FOR PREDICTING THE DEGREE OF SPREAD AND CLINICAL COURSE OF UTERUS BODY CANCER FROM ESTROGEN CONTENTS IN NORMAL AND MALIGNANT ENDOMETRIUM TISSUES | 1998 |
|
RU2151400C1 |
| METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
| METHOD OF EVALUATING ESTROGEN DEPENDENCE OF HIGH-DIFFERENTIATED THYROID CANCER | 2010 |
|
RU2422834C1 |
| AGENT INDUCING ESTROGEN AND PROGESTINE RECEPTORS | 1996 |
|
RU2126253C1 |
| METHOD FOR DETECTING DNA-DAMAGING CAPACITY OF ESTROGENS | 2001 |
|
RU2223503C2 |
| METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
| METHOD FOR COMPLEX TREATMENT OF RESECTABLE FORMS OF ENDOMETRIAL CANCER | 2005 |
|
RU2297798C1 |
| APPLICATION OF 9-OCOACRIDINE-10-ACETIC ACID AND/OR ITS SALT COMBINED WITH ANTIESTROGEN AND/OR PROGESTIN FOR TREATMENT OF STROGEN-DEPENDENT TUMOURS, METHOD OF TREATMENT AND SETS | 2007 |
|
RU2346691C2 |
